There was a 25% increase in the odds of hypomethylated (vs. hypermethylated) CCND2 promoter‐defined BC (ROR = 1.25, 95% CI = 1.06–1.48; CLR = 1.40) for a one ln‐unit increase in MPB. This evidence concerns the gene CCND2 and breast cancer.